Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Director departure
|
|
eFFECTOR Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Exercised 33,799 options to buy
@ $0.52, valued at
$17.6k
|
|
| 05/16/2023 |
4
| WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 6,401 shares
@ $0.459, valued at
$2.9k
|
|
| 05/16/2023 |
4
| Byrnes Michael (CFO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 4,863 shares
@ $0.459, valued at
$2.2k
|
|
| 01/24/2023 |
4
| Gallagher Brian M. Jr. (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 50,938 options to buy
@ $0.4688, valued at
$23.9k
|
|
| 01/24/2023 |
4
| Smither John W (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 36,875 options to buy
@ $0.4688, valued at
$17.3k
|
|
| 01/24/2023 |
4
| Harrington-Smith Kristen (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 28,125 options to buy
@ $0.4688, valued at
$13.2k
|
|
| 01/24/2023 |
4
| Klencke Barbara (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 28,125 options to buy
@ $0.4688, valued at
$13.2k
|
|
| 01/24/2023 |
4
| Ehrlich Christopher B (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 35,938 options to buy
@ $0.4688, valued at
$16.8k
|
|
| 01/24/2023 |
4
| Bhatt Elizabeth (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.4688, valued at
$14.1k
|
|
| 01/19/2023 |
4
| WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.47, valued at
$470k
|
|
| 01/19/2023 |
4
| Warner Douglas J (Chief Medical Officer) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.47, valued at
$117.5k
|
|
| 01/19/2023 |
4
| Gandhi Mayank (Chief Business Officer) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.47, valued at
$70.5k
|
|
| 01/19/2023 |
4
| Byrnes Michael (CFO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $0.47, valued at
$235k
|
|
| 11/16/2022 |
4
| Byrnes Michael (CFO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 4,651 shares
@ $0.4684, valued at
$2.2k
|
|
| 11/16/2022 |
4
| WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 6,047 shares
@ $0.4684, valued at
$2.8k
|
|
| 10/06/2022 |
4
| Ehrlich Christopher B (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Bought 346 shares
@ $0.57, valued at
$197.2 |
|
| 09/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/27/2022 |
4
| Ehrlich Christopher B (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Bought 18,867 shares
@ $0.55, valued at
$10.4k
|
|
| 08/11/2022 |
3
| Carlyle Group Inc. (10% Owner) has filed a Form 3 on eFFECTOR Therapeutics, Inc. |
| 08/08/2022 |
4
| Warner Douglas J (Chief Medical Officer) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 618,160 options to buy
@ $0.8975, valued at
$554.8k
|
|
| 08/08/2022 |
3
| Warner Douglas J (Chief Medical Officer) has filed a Form 3 on eFFECTOR Therapeutics, Inc. |
| 08/03/2022 |
4
| Presidio Management Group X LLC (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Sold 25,896 shares
@ $0.786, valued at
$20.4k
Sold 807 shares
@ $0.786, valued at
$634.3
Sold 27,348 shares
@ $0.797, valued at
$21.8k
Sold 853 shares
@ $0.797, valued at
$679.8
Sold 57,580 shares
@ $0.804, valued at
$46.3k
Sold 1,796 shares
@ $0.804, valued at
$1.4k
|
|
| 07/29/2022 |
4
| Presidio Management Group X LLC (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Sold 31,533 shares
@ $0.892, valued at
$28.1k
Sold 984 shares
@ $0.892, valued at
$877.7 |
|
| 07/27/2022 |
4
| Presidio Management Group X LLC (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Sold 2,210 shares
@ $0.931, valued at
$2.1k
Sold 69 shares
@ $0.931, valued at
$64.2
Sold 2,691 shares
@ $0.904, valued at
$2.4k
Sold 84 shares
@ $0.904, valued at
$75.9
Sold 42,344 shares
@ $0.892, valued at
$37.8k
Sold 1,321 shares
@ $0.892, valued at
$1.2k
|
|
| 07/22/2022 |
4
| Presidio Management Group X LLC (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Sold 9,726 shares
@ $1.001, valued at
$9.7k
Sold 304 shares
@ $1.001, valued at
$304.3
Sold 2,584 shares
@ $0.955, valued at
$2.5k
Sold 81 shares
@ $0.956, valued at
$77.4
Sold 7,383 shares
@ $0.91, valued at
$6.7k
Sold 231 shares
@ $0.911, valued at
$210.4 |
|
| 07/19/2022 |
4
| Presidio Management Group X LLC (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Sold 44,477 shares
@ $1.108, valued at
$49.3k
Sold 1,423 shares
@ $1.108, valued at
$1.6k
Sold 20,352 shares
@ $1.08, valued at
$22k
Sold 635 shares
@ $1.081, valued at
$686.4
Sold 2,670 shares
@ $1, valued at
$2.7k
Sold 84 shares
@ $1, valued at
$84 |
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| McNulty Alana B. (Chief Business Officer) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.49, valued at
$223.5k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Harrington-Smith Kristen (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 13,333 options to buy
@ $1.65, valued at
$22k
|
|
|
|
|